BETHESDA, MD, October 1, 2015 — Evidera, a leading provider of evidence-based solutions for the healthcare industry, is pleased to announce that Dr. Bryan Luce, PhD, MS, MBA has joined Evidera as a Senior Advisor. In this role Dr. Luce will provide thought leadership and strategic guidance to the Evidera executive leadership team, as well as counsel to Evidera’s global clients and other industry collaborators.
Dr. Luce comes to Evidera from the Patient-Centered Outcomes Research Institute (PCORI), where he served as their Chief Science Officer, leading the development and implementation of PCORI’s patient-centered comparative clinical effectiveness research (CER) agenda. Prior to his time with PCORI, Dr. Luce served as senior vice president for science policy at United BioSource Corporation (UBC), and founded the outcomes research firm MEDTAP International, serving as its chairman, president, and chief executive officer prior to its acquisition by UBC in 2004. Evidera was divested from UBC by their parent company Express Scripts in 2013.
“Bryan has always been an important part of this organization, serving not only as one of our founders but also as one of the pioneers that helped to build and shape our field, ” said Jon Williams, President and CEO, Evidera. “We’re incredibly excited to welcome Bryan to the Evidera family, and to work alongside him as he continues to build and leverage his expertise in comparative effectiveness and patient-centered outcomes research.”
Dr. Luce has focused the bulk of his career on developing and improving methods, policies and applications for evidence-based healthcare. In 2008, he founded the Pragmatic Approaches to Comparative Effectiveness (PACE) Initiative, a collaborative effort to study and improve the methods used for comparative effectiveness trials to better meet the needs of payers, policy makers and clinicians. Dr. Luce has also served in leadership roles with Battelle, the Centers for Medicare and Medicaid Services, and the Office of Technology Assessment of the United States Congress.
“I’m truly humbled to join such a talented group of scientists and consultants, and I’m excited about what the future holds for Evidera, ” Luce said. “I have been fortunate to work with many great minds and wonderful people over the course of my career, and I have no doubt that I will continue to do so with Evidera.”
Dr. Luce has authored more than 100 scientific publications, including three textbooks on health technology assessment, health policy, and health economics. He has been an advisor to numerous government and nonprofit agencies, as well as pharmaceutical and device firms worldwide. He also served as the 5th president of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and received their Avedis Donabedian Outcomes Research Lifetime Achievement Award in 2008.
Dr. Luce will continue to consult to PCORI and other organizations, and expects to be active as an affiliate research professor at the University of Washington.